脑动极光-B2024年报

BrainAurora Medical Technology Limited 腦動極光醫療科技有限公司 （於開曼群島註冊成立的有限公司） 股份代號 :6681 2024年報 246264855727778808285160166 MANAGEMENT DISCUSSION AND ANALYSIS 23131301 Deng Feng 33191910 Palm Grove Unit 4265 Smith Road, George TownP.O. Box 52A Edgewater Way, #1653Grand Cayman KY1-9006Cayman Islands •8835 MANAGEMENT DISCUSSION AND ANALYSIS 6681 133 66nao.cn 202518 1617 ICS Corporate Services (Cayman) LimitedPalm Grove Unit 4265 Smith Road, George TownP.O. Box 52A Edgewater Way, #1653Grand Cayman KY1-9006Cayman Islands 86 364 腦動極光醫療20242025 2024 1. 30150 2. 2025 ADHD6 3. 12020%20241.1931.6% 2024腦動極光Dose-response relationship betweencomputerized cognitive training and cognitive improvementNaturenpj Digital Medicine 20241腦動極光 MANAGEMENT DISCUSSION AND ANALYSIS 4. 2025185.013 202482.0%1.22315,4011.62 2025 AI 腦動極光 腦動極光醫療2025428 MANAGEMENT DISCUSSION AND ANALYSIS AIA 30150 MANAGEMENT DISCUSSION AND ANALYSIS •VDCIVDCI •NCI•PCI•CDDCIADHD MANAGEMENT DISCUSSION AND ANALYSIS MANAGEMENT DISCUSSION AND ANALYSIS MANAGEMENT DISCUSSION AND ANALYSIS MANAGEMENT DISCUSSION AND ANALYSIS 2018920206202020235202020232020202420252025 DNNDNNDNN300DNN BCATSASDSS BCAT BCAT202210BCAT MANAGEMENT DISCUSSION AND ANALYSIS 2022BCATBCAT2025 SAS SAS202212SAS2022SASSAS2025 DSS DSS20239DSS •2022720231020242025 •ADHDADHDADHD(i)(ii)ADHDADHD(IV)Achenbach MANAGEMENT DISCUSSION AND ANALYSIS •202422025 •2025 •2022722CE2026510(k) 12026(i)(ii)(iii) MANAGEMENT DISCUSSION AND ANALYSIS ISO13485 20 (i)(ii)(iii)(iv)(v) MANAGEMENT DISCUSSION AND ANALYSIS 2023123167.2020241231122.3155.1182.01% (i)(ii)(iii)(iv)(i)2023752024186(ii)2023850,00020241,800,000(iii)4,9007,397 2023123135.142024123168.3094.37%(i)23.74(ii)2023482024107 2023123132.062024123154.0168.47% MANAGEMENT DISCUSSION AND ANALYSIS (i)(ii)(iii)(iv) 202312312.08202412311.7117.79%202420231.45 202312312.32202412313.3343.53%20244.16 20231231165.222024123130.12118.23% (i)(ii)(iii)(iv)(v) 2023123138.402024123148.0225.05% MANAGEMENT DISCUSSION AND ANALYSIS (i)(ii)(iii)(iv)(v)(vi)(vii) 2023123154.402024123159.9310.17%(i)20237314685,166202427,27320239.35(ii)20235.53(iii)1.23 (i)(ii)(iii)(iv) 2023123190.7320241231119.4231.62%(i)12,739(ii)8,28720237(iii)6,69468%(iv)5,013137%1,783 MANAGEMENT DISCUSSION AND ANALYSIS (1) (i)(ii) 2023123120.222024123122.038.95% 20241231198.6120231231359.12 20241231 MANAGEMENT DISCUSSION AND ANALYSIS 20241231548.13413.38134.752024123120231231271.82141.56413.3820241231 20241231782.0156.09320.9721.2611.82 2024123121.262023123122.083.00%5.00% 202412312023 MANAGEMENT DISCUSSION AND ANALYSIS (1)(2)(3) 20241231 MANAGEMENT DISCUSSION AND ANALYSIS 2024123125.382023123129.21(i)2.02(ii)1.97(iii)3.88(i)(ii)(iii) 202412310.86 20241231 20241231 MANAGEMENT DISCUSSION AND ANALYSIS 202412311592023123120241231 2024123178.162023123175.38 MANAGEMENT DISCUSSION AND ANALYSIS 2023730 C3 202518202518 2024123120251820241231 20241231202518 MANAGEMENT DISCUSSION AND ANALYSIS 2024123120241231• 202412312023 202539 MANAGEMENT DISCUSSION AND ANALYSIS 20241231 20241231 202412312023 Deng Feng 3.10(1)3.10(2)3.10A3.10(2) 108(a) MANAGEMENT DISCUSSION AND ANALYSIS 6 8 6225 20241231ESG MANAGEMENT DISCUSSION AND ANALYSIS 20241231159202316778.16202375.38 20241231 30 20241231362024123114A MANAGEMENT DISCUSSION AND ANALYSIS 2024123165.6%202375.6%2024123125.6%202339.9% 2024123125.0%202343.9%2024123114.3%202318.7% 5% 20241231 ESG • • •••••••• 166 13.20 MANAGEMENT DISCUSSION AND ANALYSIS 13.22 37 16 28 2023 2023 7715920241231 622 20241231 2024123126 20241219 MANAGEMENT DISCUSSION AND ANALYSIS 20241219300,000 2024123120241231XV78352 XV(a)XV78(b)352(c) (1)(i)ZTanLimited275,468,000(ii)HealthbloomingLimitedHealthblooming Limited99,104,00027,129,000(2)WispiritsLimited Wiseforward LimitedNeurobrightLimited183,955,00026,946,000(3)DengFengNorthernLight Strategic Fund IV L.P.Northern Light Venture Fund IV L.P.NorthernLightPartners Fund IV L.P.126,854,000(4)Crusky Limited123,527,000(5)L MANAGEMENT DISCUSSION AND ANALYSIS (1)39,78258,239 (2)161,653 XVXV78352 2024123120241231XV23336 XV23336 MANAGEMENT DISCUSSION AND ANALYSIS (1)L(2)1,266,278,000(3)ZTan LimitedZTan Limited (4)Healthblooming LimitedHealthblooming Limited(5)27,129,000(6)Wispirits LimitedWispirits LimitedWiseforwardLimitedWiseforward LimitedWiseforward LimitedNeurobrightLimited32.82%Neurobright LimitedNeurobrightLimitedNeurobright Limited(7)26,946,000(8)Northern Light Strategic Fund IV L.P.NLSFNLVFNorthern Light Partners Fund IV L.P.NLPFNLPartners NL PartnersNorthern Light Venture Capital IV, Ltd.Deng FengNL PartnersNorthern Light Venture Capital IV, Ltd.Deng FengNLSFNLVFNLPF(9)CruskyLimitedCruskyLimited(10)Healthblooming Limited39.96%Healthblooming LimitedHealthblooming Limited(11)WisdomspiritHolding LimitedWisdomspiritHoldingLimited(12)5.57%99.99995%(i)50%(ii)44%90%(13) MANAGEMENT DISCUSSION AND ANALYSIS (1)